| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.72▲ | 3.77▼ | 3.77▼ | 3.79▼ | 3.63▲ |
| MA10 | 3.74▼ | 3.78▼ | 3.80▼ | 3.68▲ | 3.73▼ |
| MA20 | 3.77▼ | 3.81▼ | 3.81▼ | 3.64▲ | 4.24▼ |
| MA50 | 3.78▼ | 3.81▼ | 3.74▼ | 3.75▼ | 4.05▼ |
| MA100 | 3.80▼ | 3.73▼ | 3.68▲ | 4.28▼ | 2.66▲ |
| MA200 | 3.81▼ | 3.67▲ | 3.66▲ | 4.32▼ | 2.49▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.008▼ | -0.017▼ | 0.033▲ | -0.098▼ |
| RSI | 26.458▼ | 34.823▼ | 41.912▼ | 50.151▲ | 43.634▼ |
| STOCH | 10.185▼ | 51.542 | 36.096 | 62.136 | 27.968 |
| WILL %R | -69.565 | -82.051▼ | -84.444▼ | -49.515 | -70.833 |
| CCI | -109.575▼ | -237.288▼ | -139.731▼ | 45.510 | -28.378 |
|
Thursday, November 12, 2026 09:40 AM
Analyst rates Alto Ingredients as Hold, having completed a turnaround, posting 5 profitable quarters, and benefiting from 45Z clean fuel credits.
|
|
Tuesday, November 10, 2026 01:06 PM
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...
|
|
Tuesday, November 10, 2026 01:00 AM
Alto Neuroscience, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported net loss was USD 25.12 million compared to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/26 | 3.84 | 3.84 | 3.685 | 3.71 | 816,521 |
| 11/11/26 | 3.84 | 3.91 | 3.80 | 3.84 | 1,015,275 |
| 10/11/26 | 3.79 | 3.88 | 3.71 | 3.84 | 958,800 |
| 09/11/26 | 3.79 | 3.9499 | 3.7201 | 3.82 | 1,156,936 |
| 06/11/26 | 3.70 | 3.87 | 3.63 | 3.74 | 2,473,200 |
| 05/11/26 | 3.86 | 3.965 | 3.5713 | 3.67 | 1,948,435 |
| 04/11/26 | 3.54 | 3.62 | 3.49 | 3.50 | 1,186,043 |
| 03/11/26 | 3.50 | 3.585 | 3.45 | 3.55 | 839,010 |
| 02/11/26 | 3.63 | 3.63 | 3.47 | 3.50 | 865,368 |
| 30/10/26 | 3.60 | 3.665 | 3.58 | 3.65 | 625,884 |
|
|
||||
|
|
||||
|
|